Pharmabiotics 2020

  • March 10, 2020 - March 11, 2020
  • New Cap, Paris

Biomica is delighted to participate at Pharmabiotics 2020.

Dr. Shiri Meshner, Biomica’s VP of Research & Development, will be presenting at the event on the topic: “Leveraging Microbiome Functional Capabilities for the Potentiation of Immune-Checkpoint Inhibitors Therapy”.

More Details and Registration: http://www.pharmabioticsevent.com/microbiome-drug-interactions-abstracts/#meshner

 

Back to all News

Highlighted News About Biomica

ASCO 2024 logo
Apr 16, 2024

American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

We’re pleased to announce that Dr. Shiri Meshner, our VP of Research and Development, will be participating in the Pharmabiotic Conference 2024. She’ll be presenting alongside Claire Derlot, Chief Business Officer of Biose Industrie, on the topic “Biomica & Biose Industrie: The clinical journey of a multi-strain LBP”. Additionally, Dr. Meshner will contribute to a panel discussion focusing on Clinical Design & Methodology.